These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4021230)

  • 1. Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models.
    Komori S; Ishii M; Hashimoto K
    Jpn J Pharmacol; 1985 May; 38(1):73-82. PubMed ID: 4021230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic effects of optical isomers of cibenzoline on canine ventricular arrhythmias.
    Haruno A; Matsuzaki T; Hashimoto K
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):376-82. PubMed ID: 1700207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic profile of a new class 1 drug, AHR 10718, on canine atrial and ventricular arrhythmia models.
    Mitsuhashi H; Hashimoto K
    Jpn J Pharmacol; 1988 Apr; 46(4):349-58. PubMed ID: 3404765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs.
    Shibuya T; Hashimoto K; Imai S
    J Cardiovasc Pharmacol; 1983; 5(4):538-45. PubMed ID: 6193348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
    Hashimoto K; Shibuya T; Satoh H; Imai S
    Jpn Circ J; 1983 Jan; 47(1):92-7. PubMed ID: 6827775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
    Matsuzaki T; Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Feb; 231(3):363-70. PubMed ID: 8449229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):29-39. PubMed ID: 2656435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of KT-362, a new Na and Ca influx and Ca release inhibitor, on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Mochizuki S; Tomiyama A
    Jpn J Pharmacol; 1989 Dec; 51(4):475-82. PubMed ID: 2559225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models.
    Mitsuhashi H; Akiyama K; Hashimoto K; Sawa Y; Hatori Y
    Jpn J Pharmacol; 1987 Jun; 44(2):155-62. PubMed ID: 3656773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic plasma concentrations of cibenzoline on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):148-53. PubMed ID: 2435991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
    Haruno A; Hashimoto K
    Jpn J Pharmacol; 1995 May; 68(1):95-102. PubMed ID: 7494388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of betaxolol, a new beta 1 selective blocker, on canine ventricular arrhythmias.
    Mitsuhashi H; Akiyama K; Hashimoto K
    Jpn J Pharmacol; 1987 Feb; 43(2):179-85. PubMed ID: 2883336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epinephrine-induced arrhythmias and cardiovascular function after verapamil during halothane anesthesia in the dog.
    Kapur PA; Flacke WE
    Anesthesiology; 1981 Sep; 55(3):218-25. PubMed ID: 7270949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a halothane-adrenaline arrhythmia model using in vivo Guinea pigs.
    Noda Y; Hashimoto K
    J Pharmacol Sci; 2004 Jun; 95(2):234-9. PubMed ID: 15215648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
    Hashimoto K; Tsukada T; Matsuda H; Matsubara I; Imai S
    Jpn J Pharmacol; 1978 Aug; 28(4):535-44. PubMed ID: 32416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.
    Hashimoto K; Matsuzaki T; Haruno A
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):892-8. PubMed ID: 2481779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.